top of page
Treating Cancer With Precision
News
Categories
Sign up
Featured Posts
Archive
Follow Us
Apr 19, 2024
Beer Tanning TikTok Trend Should Stay in 2023 - Healthnews
And now for something a bit different! Our Chief Medical Officer, Dr. Robert Den, MD, a renowned authority when it comes to cancer, was...
Mar 25, 2024
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
JERUSALEM, March 25, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Mar 8, 2024
Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update
- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response...
Feb 26, 2024
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
JERUSALEM, February 26, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Jan 25, 2024
Alpha Tau Medical CFO Raphi Levy: "42nd Annual JP Morgan Healthcare Conference 2024: Watch out for the radiotherapy market"
Alpha Tau Medical CEO Mr. Uzi Sofer and CFO Mr. Raphi Levy were recently invited to give a presentation at the 42nd Annual JP Morgan...
Dec 20, 2023
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- The overview presentation will review some of the Company’s recent achievements, including highly promising interim results from the...
Nov 29, 2023
Alpha Tau to Participate in Sidoti Small-Cap Conference
JERUSALEM, November 29, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Nov 28, 2023
Alpha DaRT Advanced Pancreatic Cancer Trial : Highly Promising Interim Results
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no...
Nov 20, 2023
ATM submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT for Recurrent Head & Neck Cancer
Jerusalem, November 20, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the innovative...
Nov 19, 2023
Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- Treated the first patient with advanced inoperable pancreatic cancer at Hadassah Medical Center in Israel in September, alongside...
bottom of page